BuMA OCT Study(A Comparative Evaluation of BuMA Stent and of EXCEL Stent in Terms of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)

Trial Profile

BuMA OCT Study(A Comparative Evaluation of BuMA Stent and of EXCEL Stent in Terms of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Sirolimus (Primary) ; Antiplatelets
  • Indications Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders; Stent thrombosis; Unstable angina pectoris
  • Focus Therapeutic Use
  • Acronyms BuMA OCT
  • Sponsors SINO Medical Sciences Technology
  • Most Recent Events

    • 10 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 01 Nov 2013 Status changed from not yet recruiting to active, no longer recruiting as per results presented at the 25th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
    • 21 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top